Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions

Clinical Pharmacokinetics

Volumn 53, Issue 11, 2014, Pages 961-973

  Wilhelm, Abraham J ^a   den Burger, Jeroen C G ^a   Swart, Eleonora L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD FILTER; BLOOD VOLUME; DRIED BLOOD SPOT TESTING; DRUG BLOOD LEVEL; DRUG MONITORING; ELECTROSPRAY MASS SPECTROMETRY; HEMATOCRIT; HUMAN; LABORATORY AUTOMATION; LIQUID CHROMATOGRAPHY; MINIMALLY INVASIVE PROCEDURE; PLASMA PROTEIN BINDING; PRICK TEST; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; BLOOD; BLOOD SAMPLING; CHEMISTRY; NETHERLANDS; PLASMA; PROCEDURES; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; TRENDS;

IMMUNOSUPPRESSIVE AGENT;

BLOOD SPECIMEN COLLECTION; DRIED BLOOD SPOT TESTING; DRUG MONITORING; HEMATOCRIT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NETHERLANDS; PLASMA; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84920992689     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.1007/s40262-014-0177-7     Document Type: Review

References (91)

1. Shah NM, Hawwa AF, Millership JS, Collier PS, McElnay JC. A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;923–924:65–73.
2. Popov TV, Maricic LC, Prosen H, Voncina DB. Development and validation of dried blood spots technique for quantitative determination of topiramate using liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2013;27:1054–61.
3. Koop DR, Bleyle LA, Munar M, Cherala G, Al-Uzri A. Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2013;926:54–61.
4. Li Q, Cao D, Huang Y, Xu H, Yu C, Li Z. Development and validation of a sensitive LC-MS/MS method for determination of tacrolimus on dried blood spots. Biomed Chromatogr. 2013;27:327–34.
5. Egas AC, Van Maarseveen EM, Kwakkel-Van Erp JM, et al. Rapid and combined measurement of cyclosporin a, tacrolimus, sirolimus and everolimus in whole blood and dried blood spot with LC-MSMS. J Heart Lung Transplant. 2014;S33:S68.
6. Koster RA, Alffenaar JW, Greijdanus B, Uges DR. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery. Talanta. 2013;115:47–54.
7. Hoffman JT, Rossi SS, Espina-Quinto R, Letendre S, Capparelli EV. Determination of efavirenz in human dried blood spots by reversed-phase high-performance liquid chromatography with UV detection. Ther Drug Monit. 2013;35:203–8.
8. Castillo-Mancilla JR, Zheng JH, Rower JE, et al. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retrovir. 2013;29:384–90.
9. Zheng JH, Guida LA, Rower C, et al. Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS. J Pharm Biomed Anal. 2014;88:144–51.
10. Lawson G, Cocks E, Tanna S. Bisoprolol, ramipril and simvastatin determination in dried blood spot samples using LC-HRMS for assessing medication adherence. J Pharm Biomed Anal. 2013;81–82:99–107.
11. Deglon J, Thomas A, Daali Y, et al. Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite. J Pharm Biomed Anal. 2011;54:359–67.
12. Berm EJJ, Brummel-Mulder E, Paardekooper J, Hak E, Wilffert B, Maring JG. Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots using LC-MS/MS. Ther Drug Monit. 2013;35:659–60.
13. Hawwa AF, AlBawab A, Rooney M, Wedderburn LR, Beresford MW, McElnay JC. A novel dried blood spot-LCMS method for the quantification of methotrexate polyglutamates as a potential marker for methotrexate use in children. PLoS One. 2014;9:e89908.
14. la Marca G, Giocaliere E, Villanelli F, et al. Development of an UPLC-MS/MS method for the determination of antibiotic ertapenem on dried blood spots. J Pharm Biomed Anal. 2012;61:108–13.
15. Vu DH, Koster RA, Alffenaar JWC, Brouwers JRBJ, Uges DRA. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. J Chromatogr B Anal Technol Biomed Life Sci. 2011;879:1063–70.
16. Vu DH, Bolhuis MS, Koster RA, et al. Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Antimicrob Agents Chemother. 2012;56:5758–63.
17. Edelbroek PM, van der Heijden J, Stolk LM. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit. 2009;31:327–36.
18. D’Arienzo CJ, Ji QC, Discenza L, et al. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. Bioanalysis. 2010;2:1415–22.
19. Li W, Zhang J, Tse FL. Strategies in quantitative LC-MS/MS analysis of unstable small molecules in biological matrices. Biomed Chromatogr. 2011;25:258–77.
20. Meesters RJW, Hooff GP, Gruters R, Van Kampen JJA, Luider TM. Incurred sample reanalysis comparison of dried blood spots and plasma samples on the measurement of lopinavir in clinical samples. Bioanalysis. 2012;4:237–40.
21. Rao RN, Maurya PK, Ramesh M, Srinivas R, Agwane SB. Development of a validated high-throughput LC-ESI-MS method for determination of sirolimus on dried blood spots. Biomed Chromatogr. 2010;24:1356–64.
22. Shipping guidelines for dried-blood spot specimens. 2014. Ref Type: Internet Communication.
23. Timmerman P, White S, Globig S, Ludtke S, Brunet L, Smeraglia J. EBF recommendation on the validation of bioanalytical methods for dried blood spots. Bioanalysis. 2011;3:1567–75.
24. Emmons G, Rowland M. Pharmacokinetic considerations as to when to use dried blood spot sampling. Bioanalysis. 2010;2:1791–6.
25. De Kesel PM, Sadones N, Capiau S, Lambert WE, Stove CP. Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions. Bioanalysis. 2013;5:2023–41.
26. Ingels AS, De PP, Anseeuw K, et al. Dried blood spot punches for confirmation of suspected gamma-hydroxybutyric acid intoxications: validation of an optimized GC-MS procedure. Bioanalysis. 2011;3:2271–81.
27. Denniff P, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis. 2010;2:1385–95.
28. O’Mara M, Hudson-Curtis B, Olson K, Yueh Y, Dunn J, Spooner N. The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. Bioanalysis. 2011;3:2335–47.
29. Ren X, Paehler T, Zimmer M, Guo Z, Zane P, Emmons GT. Impact of various factors on radioactivity distribution in different DBS papers. Bioanalysis. 2010;2:1469–75.
30. Fan L, Lee J, Hall J, Tolentino EJ, Wu H, El-Shourbagy T. Implementing DBS methodology for the determination of Compound A in monkey blood: GLP method validation and investigation of the impact of blood spreading on performance. Bioanalysis. 2011;3:1241–52.
31. Fan L, Lee JA. Managing the effect of hematocrit on DBS analysis in a regulated environment. Bioanalysis. 2012;4:345–7.
32. Youhnovski N, Bergeron A, Furtado M, Garofolo F. Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact. Rapid Commun Mass Spectrom. 2011;25:2951–8.
33. Meesters RJW, Hooff GP. State-of-the-art dried blood spot analysis: an overview of recent advances and future trends. Bioanalysis. 2013;5:2187–208.
34. Li F, Zulkoski J, Fast D, Michael S. Perforated dried blood spots: a novel format for accurate microsampling. Bioanalysis. 2011;3:2321–33.
35. Meesters RJ, Zhang J, van Huizen NA, Hooff GP, Gruters RA, Luider TM. Dried matrix on paper disks: the next generation DBS microsampling technique for managing the hematocrit effect in DBS analysis. Bioanalysis. 2012;4:2027–35.
36. Baietto L, D’Avolio A, Ariaudo A, et al. Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots. J Chromatogr B Anal Technol Biomed Life Sci. 2013;936:42–7.
37. Baietto L, D’Avolio A, Pace S, et al. Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots. J Pharm Biomed Anal. 2014;88:66–70.
38. D’Avolio A, Simiele M, Siccardi M, et al. HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions. J Pharm Biomed Anal. 2010;52:774–80.
39. Kolocouri F, Dotsikas Y, Loukas YL. Dried plasma spots as an alternative sample collection technique for the quantitative LC-MS/MS determination of gabapentin. Anal Bioanal Chem. 2010;398:1339–47.
40. Barfield M, Wheller R. Use of dried plasma spots in the determination of pharmacokinetics in clinical studies: validation of a quantitative bioanalytical method. Anal Chem. 2011;83:118–24.
41. Li Y, Henion J, Abbott R, Wang P. The use of a membrane filtration device to form dried plasma spots for the quantitative determination of guanfacine in whole blood. Rapid Commun Mass Spectrom. 2012;26:1208–12.
42. Kim JH, Woenker T, Adamec J, Regnier FE. Simple, miniaturized blood plasma extraction method. Anal Chem. 2013;85:11501–8.
43. Capiau S, Stove VV, Lambert WE, Stove CP. Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer. Ther Drug Monit. 2013;35:659.
44. Erdi A, Thomas DP, Kakkar VV, Lane DA. Effect of low-dose subcutaneous heparin on whole-blood viscosity. Lancet. 1976;2:342–4.
45. Luckwell J, Danielson A, Johnson B, Clegg S, Green M, Pierce A. Applications and chemistry of cellulose papers for dried blood spot. In: Li W, Lee MS, editorss. Dried blood spots application and techniques. Oxford: Wiley, 2014.
46. Lawson G, Cocks E, Tanna S. Quantitative determination of atenolol in dried blood spot samples by LC-HRMS: a potential method for assessing medication adherence. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;897:72–9.
47. Li W, Doherty JP, Kulmatycki K, Smith HT, Tse FL. Simultaneous LC-MS/MS quantitation of acetaminophen and its glucuronide and sulfate metabolites in human dried blood spot samples collected by subjects in a pilot clinical study. Bioanalysis. 2012;4:1429–43.
48. Reddy TM, Tama CI, Hayes RN. A dried blood spots technique based LC-MS/MS method for the analysis of posaconazole in human whole blood samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:3626–38.
49. Luckwell J, Denniff P, Capper S, et al. Assessment of the within- and between-lot variability of Whatman FTA((R)) DMPK and 903((R)) DBS papers and their suitability for the quantitative bioanalysis of small molecules. Bioanalysis. 2013;5:2613–30.
50. Geditz MC, Lindner W, Lammerhofer M et al. Simultaneous quantification of mefloquine (+)- and (-)-enantiomers and the carboxy metabolite in dried blood spots by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013.
51. Eibak LE, Hegge AB, Rasmussen KE, et al. Alginate and chitosan foam combined with electromembrane extraction for dried blood spot analysis. Anal Chem. 2012; 84(20):8783–9.
52. Abu-Rabie P, Denniff P, Spooner N, Brynjolffssen J, Galluzzo P, Sanders G. Method of applying internal standard to dried matrix spot samples for use in quantitative bioanalysis. Anal Chem. 2011;83:8779–86.
53. Zimmer D, Hassler S, Betschart B, Sack S, Fankhauser C, Loppacher M. Internal standard application to dried blood spots by spraying: investigation of the internal standard distribution. Bioanalysis. 2013;5:711–9.
54. Deglon J, Thomas A, Cataldo A, Mangin P, Staub C. On-line desorption of dried blood spot: a novel approach for the direct LC/MS analysis of micro-whole blood samples. J Pharm Biomed Anal. 2009;49:1034–9.
55. Thomas A, Deglon J, Steimer T, Mangin P, Daali Y, Staub C. On-line desorption of dried blood spots coupled to hydrophilic interaction/reversed-phase LC/MS/MS system for the simultaneous analysis of drugs and their polar metabolites. J Sep Sci. 2010;33:873–9.
56. Ooms JA, Knegt L, Koster EH. Exploration of a new concept for automated dried blood spot analysis using flow-through desorption and online SPE-MS/MS. Bioanalysis. 2011;3:2311–20.
57. Liu J, Wang H, Manicke NE, Lin JM, Cooks RG, Ouyang Z. Development, characterization, and application of paper spray ionization. Anal Chem. 2010;82:2463–71.
58. Zhang Y, Li H, Ma Y, Lin JM. Paper spray mass spectrometry-based method for analysis of droplets in a gravity-driven microfluidic chip. Analyst. 2014;139:1023–9.
59. Manicke NE, Abu-Rabie P, Spooner N, Ouyang Z, Cooks RG. Quantitative analysis of therapeutic drugs in dried blood spot samples by paper spray mass spectrometry: an avenue to therapeutic drug monitoring. J Am Soc Mass Spectrom. 2011;22:1501–7.
60. Abu-Rabie P, Spooner N. Direct quantitative bioanalysis of drugs in dried blood spot samples using a thin-layer chromatography mass spectrometer interface. Anal Chem. 2009;81:10275–84.
61. Kertesz V, Van Berkel GJ. Fully automated liquid extraction-based surface sampling and ionization using a chip-based robotic nanoelectrospray platform. J Mass Spectrom. 2010;45:252–60.
62. Kong ST, Lim WH, Wang HY, Ng YL, Ho PC, Lim S. Comparison of dried blood spots and plasma valproic acid and carbamazepine levels. Epilepsia. 2012;53:116.
63. Gitau EN, Muchohi SN, Ogutu BR, Githiga IM, Kokwaro GO. Selective and sensitive liquid chromatographic assay of amodiaquine and desethylamodiaquine in whole blood spotted on filter paper. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;799:173–7.
64. Romsing S, Lindegardh N, Bergqvist Y. Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection. Bioanalysis. 2011;3:1847–53.
65. Chahbouni A, Sinjewel A, den Burger JC, et al. Rapid quantification of gabapentin, pregabalin, and vigabatrin in human serum by ultraperformance liquid chromatography with mass-spectrometric detection. Ther Drug Monit. 2013;35:48–53.
66. Li PK, Lee JT, Conboy KA, Ellis EF. Fluorescence polarization immunoassay for theophylline modified for use with dried blood spots on filter paper. Clin Chem. 1986;32:552–5.
67. Arpini J, Antunes MV, Pacheco LS, et al. Clinical evaluation of a dried blood spot method for determination of mycophenolic acid in renal transplant patients. Clin Biochem. 2013;46:1905–8.
68. Suyagh M, Collier PS, Millership JS, et al. Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling. Pediatrics. 2011;127:e367–74.
69. Wilhelm AJ, den Burger JC, Chahbouni A, Vos RM, Sinjewel A. Analysis of mycophenolic acid in dried blood spots using reversed phase high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:3916–9.
70. Hoogtanders K, van der Heijden J, Christiaans M, Edelbroek P, van Hooff JP, Stolk LM. Therapeutic drug monitoring of tacrolimus with the dried blood spot method. J Pharm Biomed Anal. 2007;44:658–64.
71. Nageswara RR, Satyanarayana RS, Mastan VR, Sarma VU, Girija SG. LC-ESI-MS/MS determination of paclitaxel on dried blood spots. Biomed Chromatogr. 2012;26:616–21.
72. European Medicines Agency. Guideline on bioanalytical method validation. 2012. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf. Accessed 1 Sep 2014.
73. Taylor RR, Hoffman KL, Schniedewind B, Clavijo C, Galinkin JL, Christians U. Comparison of the quantification of acetaminophen in plasma, cerebrospinal fluid and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2013; 83:1–9.
74. Rao RN, Raju SS, Vali RM, Sankar GG. Liquid chromatography-mass spectrometric determination of losartan and its active metabolite on dried blood spots. J Chromatogr B Analyt Technol Biomed Life Sci. 2012; 902:47–54.
75. la Marca G, Villanelli F, Malvagia S et al. Rapid and sensitive LC-MS/MS method for the analysis of antibiotic linezolid on dried blood spot. J Pharm Biomed Anal. 2012; 67–68:86–91.
76. Rao RN, Vali RM, Ramachandra B, Maurya PK. Rapid determination of rifaximin on dried blood spots by LC-ESI-MS. Biomed Chromatogr. 2011; 25:1201–1207.
77. la Marca G, Malvagia S, Filippi L et al. Rapid assay of rufinamide in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. J Pharm Biomed Anal. 2011; 54:192–197.
78. la MG, Malvagia S, Filippi L, Luceri F, Moneti G, Guerrini R. A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry. Epilepsia 2009; 50:2658–2662.
79. Deglon J, Lauer E, Thomas A, Mangin P, Staub C. Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fluoxetine, norfluoxetine, reboxetine, and paroxetine analysis. Anal Bioanal Chem. 2010; 396:2523–2532.
80. Van Der Elst KCM, Span LFR, Van Hateren K et al. Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole. Antimicrob Agents Chemother. 2013; 57:4999–5004.
81. Jimmerson LC, Zheng JH, Bushman LR, MacBrayne CE, Anderson PL, Kiser JJ. Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2014; 944:18–24.
82. Meesters RJW, Van Kampen JJA, Reedijk ML et al. Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots. Anal Bioanal Chem. 2010; 398:319–328.
83. Suyagh MF, Kole PL, Millership J, Collier P, Halliday H, McElnay JC. Development and validation of a dried blood spot-LC-APCI-MS assay for estimation of canrenone in paediatric samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2010; 878:769–776.
84. Yakkundi S, Millership J, Collier P, Shields MD, McElnay J. Development andvalidation of a dried blood spot LC-MS/MS assay to quantify ranitidine in paediatricsamples. J Pharm Biomed Anal. 2011; 56:1057–1063.
85. Wilhelm AJ, Klijn A, Burger JCG, Veldkamp AI, Janssen JJWM, Swart N. Validation of dried blood spot sampling in therapeutic drug monitoring of cyclosporin. Ther Drug Monit. 2011; 33:545.
86. Wilhelm AJ, Klijn A, Den Burger JCG et al. Clinical validation of dried blood spotsampling in therapeutic drug monitoring of ciclosporin a in allogeneic stem cell transplant recipients: Direct comparison between capillary and venous sampling. Ther Drug Monit. 2013; 35:92–95.
87. Sadilkova K, Busby B, Dickerson JA, Rutledge JC, Jack RM. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS. Clin Chim Acta. 2013; 421:152–156.
88. Ansari M, Uppugunduri CR, Deglon J et al. A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2012; 26:1437–1446.
89. Kralj E, Trontelj J, Pajic T, Kristl A. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2012; 903:150–156.
90. Hatami M, Karimnia E, Farhadi K. Determination of salmeterol in dried blood spot using an ionic liquid based dispersive liquid-liquid microextraction coupled with HPLC. J Pharm Biomed Anal. 2013; 85:283–287.
91. Della Bona ML, Malvagia S, Villanelli F et al. A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots. J Pharm Biomed Anal. 2013; 78–79:34–38.